Global OTC Transdermal Analgesic Patches Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global OTC Transdermal Analgesic Patches market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global OTC Transdermal Analgesic Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global OTC Transdermal Analgesic Patches market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Transdermal Analgesic Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Transdermal Analgesic Patches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Transdermal Analgesic Patches market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for OTC Transdermal Analgesic Patches
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global OTC Transdermal Analgesic Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu, Mylan, Johnson & Johnson, Teva and Lingrui, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
OTC Transdermal Analgesic Patches market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe OTC Transdermal Analgesic Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of OTC Transdermal Analgesic Patches, with price, sales, revenue and global market share of OTC Transdermal Analgesic Patches from 2018 to 2023.
Chapter 3, the OTC Transdermal Analgesic Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Transdermal Analgesic Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and OTC Transdermal Analgesic Patches market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of OTC Transdermal Analgesic Patches.
Chapter 14 and 15, to describe OTC Transdermal Analgesic Patches sales channel, distributors, customers, research findings and conclusion.
This report is a detailed and comprehensive analysis for global OTC Transdermal Analgesic Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global OTC Transdermal Analgesic Patches market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Transdermal Analgesic Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Transdermal Analgesic Patches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global OTC Transdermal Analgesic Patches market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for OTC Transdermal Analgesic Patches
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global OTC Transdermal Analgesic Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Hisamitsu, Mylan, Johnson & Johnson, Teva and Lingrui, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
OTC Transdermal Analgesic Patches market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Lidocaine Patches
- Diclofenac Patches
- Indomethacin Patches
- Counter-Irritant Patches
- Others
- Pharmacy
- Clinic
- Others
- Hisamitsu
- Mylan
- Johnson & Johnson
- Teva
- Lingrui
- Sanofi
- Qizheng
- Endo
- Huarun 999
- GSK
- Haw Par
- Nichiban
- Laboratoires Genevrier
- BLUE-EMU
- IBSA Group
- Pfizer
- Performance Health
- Actavis
- Teikoku Seiyaku
- Novartis
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe OTC Transdermal Analgesic Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of OTC Transdermal Analgesic Patches, with price, sales, revenue and global market share of OTC Transdermal Analgesic Patches from 2018 to 2023.
Chapter 3, the OTC Transdermal Analgesic Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the OTC Transdermal Analgesic Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and OTC Transdermal Analgesic Patches market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of OTC Transdermal Analgesic Patches.
Chapter 14 and 15, to describe OTC Transdermal Analgesic Patches sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of OTC Transdermal Analgesic Patches
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global OTC Transdermal Analgesic Patches Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lidocaine Patches
1.3.3 Diclofenac Patches
1.3.4 Indomethacin Patches
1.3.5 Counter-Irritant Patches
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global OTC Transdermal Analgesic Patches Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmacy
1.4.3 Clinic
1.4.4 Others
1.5 Global OTC Transdermal Analgesic Patches Market Size & Forecast
1.5.1 Global OTC Transdermal Analgesic Patches Consumption Value (2018 & 2022 & 2029)
1.5.2 Global OTC Transdermal Analgesic Patches Sales Quantity (2018-2029)
1.5.3 Global OTC Transdermal Analgesic Patches Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Hisamitsu
2.1.1 Hisamitsu Details
2.1.2 Hisamitsu Major Business
2.1.3 Hisamitsu OTC Transdermal Analgesic Patches Product and Services
2.1.4 Hisamitsu OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hisamitsu Recent Developments/Updates
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan OTC Transdermal Analgesic Patches Product and Services
2.2.4 Mylan OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mylan Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
2.3.4 Johnson & Johnson OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva OTC Transdermal Analgesic Patches Product and Services
2.4.4 Teva OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Recent Developments/Updates
2.5 Lingrui
2.5.1 Lingrui Details
2.5.2 Lingrui Major Business
2.5.3 Lingrui OTC Transdermal Analgesic Patches Product and Services
2.5.4 Lingrui OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lingrui Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi OTC Transdermal Analgesic Patches Product and Services
2.6.4 Sanofi OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi Recent Developments/Updates
2.7 Qizheng
2.7.1 Qizheng Details
2.7.2 Qizheng Major Business
2.7.3 Qizheng OTC Transdermal Analgesic Patches Product and Services
2.7.4 Qizheng OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qizheng Recent Developments/Updates
2.8 Endo
2.8.1 Endo Details
2.8.2 Endo Major Business
2.8.3 Endo OTC Transdermal Analgesic Patches Product and Services
2.8.4 Endo OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Endo Recent Developments/Updates
2.9 Huarun
2.9.1 Huarun 999 Details
2.9.2 Huarun 999 Major Business
2.9.3 Huarun 999 OTC Transdermal Analgesic Patches Product and Services
2.9.4 Huarun 999 OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Huarun 999 Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK OTC Transdermal Analgesic Patches Product and Services
2.10.4 GSK OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GSK Recent Developments/Updates
2.11 Haw Par
2.11.1 Haw Par Details
2.11.2 Haw Par Major Business
2.11.3 Haw Par OTC Transdermal Analgesic Patches Product and Services
2.11.4 Haw Par OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Haw Par Recent Developments/Updates
2.12 Nichiban
2.12.1 Nichiban Details
2.12.2 Nichiban Major Business
2.12.3 Nichiban OTC Transdermal Analgesic Patches Product and Services
2.12.4 Nichiban OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Nichiban Recent Developments/Updates
2.13 Laboratoires Genevrier
2.13.1 Laboratoires Genevrier Details
2.13.2 Laboratoires Genevrier Major Business
2.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
2.13.4 Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Laboratoires Genevrier Recent Developments/Updates
2.14 BLUE-EMU
2.14.1 BLUE-EMU Details
2.14.2 BLUE-EMU Major Business
2.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
2.14.4 BLUE-EMU OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 BLUE-EMU Recent Developments/Updates
2.15 IBSA Group
2.15.1 IBSA Group Details
2.15.2 IBSA Group Major Business
2.15.3 IBSA Group OTC Transdermal Analgesic Patches Product and Services
2.15.4 IBSA Group OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 IBSA Group Recent Developments/Updates
2.16 Pfizer
2.16.1 Pfizer Details
2.16.2 Pfizer Major Business
2.16.3 Pfizer OTC Transdermal Analgesic Patches Product and Services
2.16.4 Pfizer OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Pfizer Recent Developments/Updates
2.17 Performance Health
2.17.1 Performance Health Details
2.17.2 Performance Health Major Business
2.17.3 Performance Health OTC Transdermal Analgesic Patches Product and Services
2.17.4 Performance Health OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Performance Health Recent Developments/Updates
2.18 Actavis
2.18.1 Actavis Details
2.18.2 Actavis Major Business
2.18.3 Actavis OTC Transdermal Analgesic Patches Product and Services
2.18.4 Actavis OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Actavis Recent Developments/Updates
2.19 Teikoku Seiyaku
2.19.1 Teikoku Seiyaku Details
2.19.2 Teikoku Seiyaku Major Business
2.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
2.19.4 Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Teikoku Seiyaku Recent Developments/Updates
2.20 Novartis
2.20.1 Novartis Details
2.20.2 Novartis Major Business
2.20.3 Novartis OTC Transdermal Analgesic Patches Product and Services
2.20.4 Novartis OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Novartis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OTC TRANSDERMAL ANALGESIC PATCHES BY MANUFACTURER
3.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Manufacturer (2018-2023)
3.2 Global OTC Transdermal Analgesic Patches Revenue by Manufacturer (2018-2023)
3.3 Global OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of OTC Transdermal Analgesic Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 OTC Transdermal Analgesic Patches Manufacturer Market Share in 2022
3.4.2 Top 6 OTC Transdermal Analgesic Patches Manufacturer Market Share in 2022
3.5 OTC Transdermal Analgesic Patches Market: Overall Company Footprint Analysis
3.5.1 OTC Transdermal Analgesic Patches Market: Region Footprint
3.5.2 OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
3.5.3 OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global OTC Transdermal Analgesic Patches Market Size by Region
4.1.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2029)
4.1.2 Global OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2029)
4.1.3 Global OTC Transdermal Analgesic Patches Average Price by Region (2018-2029)
4.2 North America OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.3 Europe OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.4 Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.5 South America OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.6 Middle East and Africa OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
5.2 Global OTC Transdermal Analgesic Patches Consumption Value by Type (2018-2029)
5.3 Global OTC Transdermal Analgesic Patches Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
6.2 Global OTC Transdermal Analgesic Patches Consumption Value by Application (2018-2029)
6.3 Global OTC Transdermal Analgesic Patches Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
7.2 North America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
7.3 North America OTC Transdermal Analgesic Patches Market Size by Country
7.3.1 North America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
7.3.2 North America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
8.2 Europe OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
8.3 Europe OTC Transdermal Analgesic Patches Market Size by Country
8.3.1 Europe OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
8.3.2 Europe OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific OTC Transdermal Analgesic Patches Market Size by Region
9.3.1 Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
10.2 South America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
10.3 South America OTC Transdermal Analgesic Patches Market Size by Country
10.3.1 South America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
10.3.2 South America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa OTC Transdermal Analgesic Patches Market Size by Country
11.3.1 Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 OTC Transdermal Analgesic Patches Market Drivers
12.2 OTC Transdermal Analgesic Patches Market Restraints
12.3 OTC Transdermal Analgesic Patches Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of OTC Transdermal Analgesic Patches and Key Manufacturers
13.2 Manufacturing Costs Percentage of OTC Transdermal Analgesic Patches
13.3 OTC Transdermal Analgesic Patches Production Process
13.4 OTC Transdermal Analgesic Patches Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 OTC Transdermal Analgesic Patches Typical Distributors
14.3 OTC Transdermal Analgesic Patches Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of OTC Transdermal Analgesic Patches
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global OTC Transdermal Analgesic Patches Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lidocaine Patches
1.3.3 Diclofenac Patches
1.3.4 Indomethacin Patches
1.3.5 Counter-Irritant Patches
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global OTC Transdermal Analgesic Patches Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmacy
1.4.3 Clinic
1.4.4 Others
1.5 Global OTC Transdermal Analgesic Patches Market Size & Forecast
1.5.1 Global OTC Transdermal Analgesic Patches Consumption Value (2018 & 2022 & 2029)
1.5.2 Global OTC Transdermal Analgesic Patches Sales Quantity (2018-2029)
1.5.3 Global OTC Transdermal Analgesic Patches Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Hisamitsu
2.1.1 Hisamitsu Details
2.1.2 Hisamitsu Major Business
2.1.3 Hisamitsu OTC Transdermal Analgesic Patches Product and Services
2.1.4 Hisamitsu OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Hisamitsu Recent Developments/Updates
2.2 Mylan
2.2.1 Mylan Details
2.2.2 Mylan Major Business
2.2.3 Mylan OTC Transdermal Analgesic Patches Product and Services
2.2.4 Mylan OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Mylan Recent Developments/Updates
2.3 Johnson & Johnson
2.3.1 Johnson & Johnson Details
2.3.2 Johnson & Johnson Major Business
2.3.3 Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
2.3.4 Johnson & Johnson OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Johnson & Johnson Recent Developments/Updates
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business
2.4.3 Teva OTC Transdermal Analgesic Patches Product and Services
2.4.4 Teva OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Teva Recent Developments/Updates
2.5 Lingrui
2.5.1 Lingrui Details
2.5.2 Lingrui Major Business
2.5.3 Lingrui OTC Transdermal Analgesic Patches Product and Services
2.5.4 Lingrui OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lingrui Recent Developments/Updates
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business
2.6.3 Sanofi OTC Transdermal Analgesic Patches Product and Services
2.6.4 Sanofi OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi Recent Developments/Updates
2.7 Qizheng
2.7.1 Qizheng Details
2.7.2 Qizheng Major Business
2.7.3 Qizheng OTC Transdermal Analgesic Patches Product and Services
2.7.4 Qizheng OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qizheng Recent Developments/Updates
2.8 Endo
2.8.1 Endo Details
2.8.2 Endo Major Business
2.8.3 Endo OTC Transdermal Analgesic Patches Product and Services
2.8.4 Endo OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Endo Recent Developments/Updates
2.9 Huarun
2.9.1 Huarun 999 Details
2.9.2 Huarun 999 Major Business
2.9.3 Huarun 999 OTC Transdermal Analgesic Patches Product and Services
2.9.4 Huarun 999 OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Huarun 999 Recent Developments/Updates
2.10 GSK
2.10.1 GSK Details
2.10.2 GSK Major Business
2.10.3 GSK OTC Transdermal Analgesic Patches Product and Services
2.10.4 GSK OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GSK Recent Developments/Updates
2.11 Haw Par
2.11.1 Haw Par Details
2.11.2 Haw Par Major Business
2.11.3 Haw Par OTC Transdermal Analgesic Patches Product and Services
2.11.4 Haw Par OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Haw Par Recent Developments/Updates
2.12 Nichiban
2.12.1 Nichiban Details
2.12.2 Nichiban Major Business
2.12.3 Nichiban OTC Transdermal Analgesic Patches Product and Services
2.12.4 Nichiban OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Nichiban Recent Developments/Updates
2.13 Laboratoires Genevrier
2.13.1 Laboratoires Genevrier Details
2.13.2 Laboratoires Genevrier Major Business
2.13.3 Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
2.13.4 Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Laboratoires Genevrier Recent Developments/Updates
2.14 BLUE-EMU
2.14.1 BLUE-EMU Details
2.14.2 BLUE-EMU Major Business
2.14.3 BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
2.14.4 BLUE-EMU OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 BLUE-EMU Recent Developments/Updates
2.15 IBSA Group
2.15.1 IBSA Group Details
2.15.2 IBSA Group Major Business
2.15.3 IBSA Group OTC Transdermal Analgesic Patches Product and Services
2.15.4 IBSA Group OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 IBSA Group Recent Developments/Updates
2.16 Pfizer
2.16.1 Pfizer Details
2.16.2 Pfizer Major Business
2.16.3 Pfizer OTC Transdermal Analgesic Patches Product and Services
2.16.4 Pfizer OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Pfizer Recent Developments/Updates
2.17 Performance Health
2.17.1 Performance Health Details
2.17.2 Performance Health Major Business
2.17.3 Performance Health OTC Transdermal Analgesic Patches Product and Services
2.17.4 Performance Health OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Performance Health Recent Developments/Updates
2.18 Actavis
2.18.1 Actavis Details
2.18.2 Actavis Major Business
2.18.3 Actavis OTC Transdermal Analgesic Patches Product and Services
2.18.4 Actavis OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Actavis Recent Developments/Updates
2.19 Teikoku Seiyaku
2.19.1 Teikoku Seiyaku Details
2.19.2 Teikoku Seiyaku Major Business
2.19.3 Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
2.19.4 Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Teikoku Seiyaku Recent Developments/Updates
2.20 Novartis
2.20.1 Novartis Details
2.20.2 Novartis Major Business
2.20.3 Novartis OTC Transdermal Analgesic Patches Product and Services
2.20.4 Novartis OTC Transdermal Analgesic Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Novartis Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OTC TRANSDERMAL ANALGESIC PATCHES BY MANUFACTURER
3.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Manufacturer (2018-2023)
3.2 Global OTC Transdermal Analgesic Patches Revenue by Manufacturer (2018-2023)
3.3 Global OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of OTC Transdermal Analgesic Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 OTC Transdermal Analgesic Patches Manufacturer Market Share in 2022
3.4.2 Top 6 OTC Transdermal Analgesic Patches Manufacturer Market Share in 2022
3.5 OTC Transdermal Analgesic Patches Market: Overall Company Footprint Analysis
3.5.1 OTC Transdermal Analgesic Patches Market: Region Footprint
3.5.2 OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
3.5.3 OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global OTC Transdermal Analgesic Patches Market Size by Region
4.1.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2029)
4.1.2 Global OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2029)
4.1.3 Global OTC Transdermal Analgesic Patches Average Price by Region (2018-2029)
4.2 North America OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.3 Europe OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.4 Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.5 South America OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
4.6 Middle East and Africa OTC Transdermal Analgesic Patches Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
5.2 Global OTC Transdermal Analgesic Patches Consumption Value by Type (2018-2029)
5.3 Global OTC Transdermal Analgesic Patches Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
6.2 Global OTC Transdermal Analgesic Patches Consumption Value by Application (2018-2029)
6.3 Global OTC Transdermal Analgesic Patches Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
7.2 North America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
7.3 North America OTC Transdermal Analgesic Patches Market Size by Country
7.3.1 North America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
7.3.2 North America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
8.2 Europe OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
8.3 Europe OTC Transdermal Analgesic Patches Market Size by Country
8.3.1 Europe OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
8.3.2 Europe OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific OTC Transdermal Analgesic Patches Market Size by Region
9.3.1 Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
10.2 South America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
10.3 South America OTC Transdermal Analgesic Patches Market Size by Country
10.3.1 South America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
10.3.2 South America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa OTC Transdermal Analgesic Patches Market Size by Country
11.3.1 Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 OTC Transdermal Analgesic Patches Market Drivers
12.2 OTC Transdermal Analgesic Patches Market Restraints
12.3 OTC Transdermal Analgesic Patches Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of OTC Transdermal Analgesic Patches and Key Manufacturers
13.2 Manufacturing Costs Percentage of OTC Transdermal Analgesic Patches
13.3 OTC Transdermal Analgesic Patches Production Process
13.4 OTC Transdermal Analgesic Patches Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 OTC Transdermal Analgesic Patches Typical Distributors
14.3 OTC Transdermal Analgesic Patches Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global OTC Transdermal Analgesic Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global OTC Transdermal Analgesic Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Major Business
Table 5. Hisamitsu OTC Transdermal Analgesic Patches Product and Services
Table 6. Hisamitsu OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Hisamitsu Recent Developments/Updates
Table 8. Mylan Basic Information, Manufacturing Base and Competitors
Table 9. Mylan Major Business
Table 10. Mylan OTC Transdermal Analgesic Patches Product and Services
Table 11. Mylan OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Mylan Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
Table 16. Johnson & Johnson OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Teva Basic Information, Manufacturing Base and Competitors
Table 19. Teva Major Business
Table 20. Teva OTC Transdermal Analgesic Patches Product and Services
Table 21. Teva OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Recent Developments/Updates
Table 23. Lingrui Basic Information, Manufacturing Base and Competitors
Table 24. Lingrui Major Business
Table 25. Lingrui OTC Transdermal Analgesic Patches Product and Services
Table 26. Lingrui OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lingrui Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi OTC Transdermal Analgesic Patches Product and Services
Table 31. Sanofi OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanofi Recent Developments/Updates
Table 33. Qizheng Basic Information, Manufacturing Base and Competitors
Table 34. Qizheng Major Business
Table 35. Qizheng OTC Transdermal Analgesic Patches Product and Services
Table 36. Qizheng OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Qizheng Recent Developments/Updates
Table 38. Endo Basic Information, Manufacturing Base and Competitors
Table 39. Endo Major Business
Table 40. Endo OTC Transdermal Analgesic Patches Product and Services
Table 41. Endo OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Endo Recent Developments/Updates
Table 43. Huarun 999 Basic Information, Manufacturing Base and Competitors
Table 44. Huarun 999 Major Business
Table 45. Huarun 999 OTC Transdermal Analgesic Patches Product and Services
Table 46. Huarun 999 OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Huarun 999 Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK OTC Transdermal Analgesic Patches Product and Services
Table 51. GSK OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GSK Recent Developments/Updates
Table 53. Haw Par Basic Information, Manufacturing Base and Competitors
Table 54. Haw Par Major Business
Table 55. Haw Par OTC Transdermal Analgesic Patches Product and Services
Table 56. Haw Par OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Haw Par Recent Developments/Updates
Table 58. Nichiban Basic Information, Manufacturing Base and Competitors
Table 59. Nichiban Major Business
Table 60. Nichiban OTC Transdermal Analgesic Patches Product and Services
Table 61. Nichiban OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Nichiban Recent Developments/Updates
Table 63. Laboratoires Genevrier Basic Information, Manufacturing Base and Competitors
Table 64. Laboratoires Genevrier Major Business
Table 65. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
Table 66. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Laboratoires Genevrier Recent Developments/Updates
Table 68. BLUE-EMU Basic Information, Manufacturing Base and Competitors
Table 69. BLUE-EMU Major Business
Table 70. BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
Table 71. BLUE-EMU OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. BLUE-EMU Recent Developments/Updates
Table 73. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 74. IBSA Group Major Business
Table 75. IBSA Group OTC Transdermal Analgesic Patches Product and Services
Table 76. IBSA Group OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. IBSA Group Recent Developments/Updates
Table 78. Pfizer Basic Information, Manufacturing Base and Competitors
Table 79. Pfizer Major Business
Table 80. Pfizer OTC Transdermal Analgesic Patches Product and Services
Table 81. Pfizer OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Pfizer Recent Developments/Updates
Table 83. Performance Health Basic Information, Manufacturing Base and Competitors
Table 84. Performance Health Major Business
Table 85. Performance Health OTC Transdermal Analgesic Patches Product and Services
Table 86. Performance Health OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Performance Health Recent Developments/Updates
Table 88. Actavis Basic Information, Manufacturing Base and Competitors
Table 89. Actavis Major Business
Table 90. Actavis OTC Transdermal Analgesic Patches Product and Services
Table 91. Actavis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Actavis Recent Developments/Updates
Table 93. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 94. Teikoku Seiyaku Major Business
Table 95. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
Table 96. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Teikoku Seiyaku Recent Developments/Updates
Table 98. Novartis Basic Information, Manufacturing Base and Competitors
Table 99. Novartis Major Business
Table 100. Novartis OTC Transdermal Analgesic Patches Product and Services
Table 101. Novartis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Novartis Recent Developments/Updates
Table 103. Global OTC Transdermal Analgesic Patches Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global OTC Transdermal Analgesic Patches Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in OTC Transdermal Analgesic Patches, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and OTC Transdermal Analgesic Patches Production Site of Key Manufacturer
Table 108. OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
Table 109. OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
Table 110. OTC Transdermal Analgesic Patches New Market Entrants and Barriers to Market Entry
Table 111. OTC Transdermal Analgesic Patches Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global OTC Transdermal Analgesic Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global OTC Transdermal Analgesic Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global OTC Transdermal Analgesic Patches Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global OTC Transdermal Analgesic Patches Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global OTC Transdermal Analgesic Patches Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global OTC Transdermal Analgesic Patches Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global OTC Transdermal Analgesic Patches Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global OTC Transdermal Analgesic Patches Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global OTC Transdermal Analgesic Patches Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global OTC Transdermal Analgesic Patches Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global OTC Transdermal Analgesic Patches Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global OTC Transdermal Analgesic Patches Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America OTC Transdermal Analgesic Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America OTC Transdermal Analgesic Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe OTC Transdermal Analgesic Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe OTC Transdermal Analgesic Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America OTC Transdermal Analgesic Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America OTC Transdermal Analgesic Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 170. OTC Transdermal Analgesic Patches Raw Material
Table 171. Key Manufacturers of OTC Transdermal Analgesic Patches Raw Materials
Table 172. OTC Transdermal Analgesic Patches Typical Distributors
Table 173. OTC Transdermal Analgesic Patches Typical Customers
Table 1. Global OTC Transdermal Analgesic Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global OTC Transdermal Analgesic Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 4. Hisamitsu Major Business
Table 5. Hisamitsu OTC Transdermal Analgesic Patches Product and Services
Table 6. Hisamitsu OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Hisamitsu Recent Developments/Updates
Table 8. Mylan Basic Information, Manufacturing Base and Competitors
Table 9. Mylan Major Business
Table 10. Mylan OTC Transdermal Analgesic Patches Product and Services
Table 11. Mylan OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Mylan Recent Developments/Updates
Table 13. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 14. Johnson & Johnson Major Business
Table 15. Johnson & Johnson OTC Transdermal Analgesic Patches Product and Services
Table 16. Johnson & Johnson OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Johnson & Johnson Recent Developments/Updates
Table 18. Teva Basic Information, Manufacturing Base and Competitors
Table 19. Teva Major Business
Table 20. Teva OTC Transdermal Analgesic Patches Product and Services
Table 21. Teva OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Teva Recent Developments/Updates
Table 23. Lingrui Basic Information, Manufacturing Base and Competitors
Table 24. Lingrui Major Business
Table 25. Lingrui OTC Transdermal Analgesic Patches Product and Services
Table 26. Lingrui OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lingrui Recent Developments/Updates
Table 28. Sanofi Basic Information, Manufacturing Base and Competitors
Table 29. Sanofi Major Business
Table 30. Sanofi OTC Transdermal Analgesic Patches Product and Services
Table 31. Sanofi OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Sanofi Recent Developments/Updates
Table 33. Qizheng Basic Information, Manufacturing Base and Competitors
Table 34. Qizheng Major Business
Table 35. Qizheng OTC Transdermal Analgesic Patches Product and Services
Table 36. Qizheng OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Qizheng Recent Developments/Updates
Table 38. Endo Basic Information, Manufacturing Base and Competitors
Table 39. Endo Major Business
Table 40. Endo OTC Transdermal Analgesic Patches Product and Services
Table 41. Endo OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Endo Recent Developments/Updates
Table 43. Huarun 999 Basic Information, Manufacturing Base and Competitors
Table 44. Huarun 999 Major Business
Table 45. Huarun 999 OTC Transdermal Analgesic Patches Product and Services
Table 46. Huarun 999 OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Huarun 999 Recent Developments/Updates
Table 48. GSK Basic Information, Manufacturing Base and Competitors
Table 49. GSK Major Business
Table 50. GSK OTC Transdermal Analgesic Patches Product and Services
Table 51. GSK OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. GSK Recent Developments/Updates
Table 53. Haw Par Basic Information, Manufacturing Base and Competitors
Table 54. Haw Par Major Business
Table 55. Haw Par OTC Transdermal Analgesic Patches Product and Services
Table 56. Haw Par OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Haw Par Recent Developments/Updates
Table 58. Nichiban Basic Information, Manufacturing Base and Competitors
Table 59. Nichiban Major Business
Table 60. Nichiban OTC Transdermal Analgesic Patches Product and Services
Table 61. Nichiban OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Nichiban Recent Developments/Updates
Table 63. Laboratoires Genevrier Basic Information, Manufacturing Base and Competitors
Table 64. Laboratoires Genevrier Major Business
Table 65. Laboratoires Genevrier OTC Transdermal Analgesic Patches Product and Services
Table 66. Laboratoires Genevrier OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Laboratoires Genevrier Recent Developments/Updates
Table 68. BLUE-EMU Basic Information, Manufacturing Base and Competitors
Table 69. BLUE-EMU Major Business
Table 70. BLUE-EMU OTC Transdermal Analgesic Patches Product and Services
Table 71. BLUE-EMU OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. BLUE-EMU Recent Developments/Updates
Table 73. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 74. IBSA Group Major Business
Table 75. IBSA Group OTC Transdermal Analgesic Patches Product and Services
Table 76. IBSA Group OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. IBSA Group Recent Developments/Updates
Table 78. Pfizer Basic Information, Manufacturing Base and Competitors
Table 79. Pfizer Major Business
Table 80. Pfizer OTC Transdermal Analgesic Patches Product and Services
Table 81. Pfizer OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Pfizer Recent Developments/Updates
Table 83. Performance Health Basic Information, Manufacturing Base and Competitors
Table 84. Performance Health Major Business
Table 85. Performance Health OTC Transdermal Analgesic Patches Product and Services
Table 86. Performance Health OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. Performance Health Recent Developments/Updates
Table 88. Actavis Basic Information, Manufacturing Base and Competitors
Table 89. Actavis Major Business
Table 90. Actavis OTC Transdermal Analgesic Patches Product and Services
Table 91. Actavis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Actavis Recent Developments/Updates
Table 93. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 94. Teikoku Seiyaku Major Business
Table 95. Teikoku Seiyaku OTC Transdermal Analgesic Patches Product and Services
Table 96. Teikoku Seiyaku OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Teikoku Seiyaku Recent Developments/Updates
Table 98. Novartis Basic Information, Manufacturing Base and Competitors
Table 99. Novartis Major Business
Table 100. Novartis OTC Transdermal Analgesic Patches Product and Services
Table 101. Novartis OTC Transdermal Analgesic Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 102. Novartis Recent Developments/Updates
Table 103. Global OTC Transdermal Analgesic Patches Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 104. Global OTC Transdermal Analgesic Patches Revenue by Manufacturer (2018-2023) & (USD Million)
Table 105. Global OTC Transdermal Analgesic Patches Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 106. Market Position of Manufacturers in OTC Transdermal Analgesic Patches, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 107. Head Office and OTC Transdermal Analgesic Patches Production Site of Key Manufacturer
Table 108. OTC Transdermal Analgesic Patches Market: Company Product Type Footprint
Table 109. OTC Transdermal Analgesic Patches Market: Company Product Application Footprint
Table 110. OTC Transdermal Analgesic Patches New Market Entrants and Barriers to Market Entry
Table 111. OTC Transdermal Analgesic Patches Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 113. Global OTC Transdermal Analgesic Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 114. Global OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 115. Global OTC Transdermal Analgesic Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 116. Global OTC Transdermal Analgesic Patches Average Price by Region (2018-2023) & (US$/Unit)
Table 117. Global OTC Transdermal Analgesic Patches Average Price by Region (2024-2029) & (US$/Unit)
Table 118. Global OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Global OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Global OTC Transdermal Analgesic Patches Consumption Value by Type (2018-2023) & (USD Million)
Table 121. Global OTC Transdermal Analgesic Patches Consumption Value by Type (2024-2029) & (USD Million)
Table 122. Global OTC Transdermal Analgesic Patches Average Price by Type (2018-2023) & (US$/Unit)
Table 123. Global OTC Transdermal Analgesic Patches Average Price by Type (2024-2029) & (US$/Unit)
Table 124. Global OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Global OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Global OTC Transdermal Analgesic Patches Consumption Value by Application (2018-2023) & (USD Million)
Table 127. Global OTC Transdermal Analgesic Patches Consumption Value by Application (2024-2029) & (USD Million)
Table 128. Global OTC Transdermal Analgesic Patches Average Price by Application (2018-2023) & (US$/Unit)
Table 129. Global OTC Transdermal Analgesic Patches Average Price by Application (2024-2029) & (US$/Unit)
Table 130. North America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 131. North America OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 132. North America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 133. North America OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 134. North America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 135. North America OTC Transdermal Analgesic Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 136. North America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 137. North America OTC Transdermal Analgesic Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 138. Europe OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 139. Europe OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 140. Europe OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 141. Europe OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 142. Europe OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 143. Europe OTC Transdermal Analgesic Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 144. Europe OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe OTC Transdermal Analgesic Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 147. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 148. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 149. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 150. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 151. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 152. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 153. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 154. South America OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 155. South America OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 156. South America OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 157. South America OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 158. South America OTC Transdermal Analgesic Patches Sales Quantity by Country (2018-2023) & (K Units)
Table 159. South America OTC Transdermal Analgesic Patches Sales Quantity by Country (2024-2029) & (K Units)
Table 160. South America OTC Transdermal Analgesic Patches Consumption Value by Country (2018-2023) & (USD Million)
Table 161. South America OTC Transdermal Analgesic Patches Consumption Value by Country (2024-2029) & (USD Million)
Table 162. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Type (2018-2023) & (K Units)
Table 163. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Type (2024-2029) & (K Units)
Table 164. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Application (2018-2023) & (K Units)
Table 165. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Application (2024-2029) & (K Units)
Table 166. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Region (2018-2023) & (K Units)
Table 167. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity by Region (2024-2029) & (K Units)
Table 168. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value by Region (2018-2023) & (USD Million)
Table 169. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value by Region (2024-2029) & (USD Million)
Table 170. OTC Transdermal Analgesic Patches Raw Material
Table 171. Key Manufacturers of OTC Transdermal Analgesic Patches Raw Materials
Table 172. OTC Transdermal Analgesic Patches Typical Distributors
Table 173. OTC Transdermal Analgesic Patches Typical Customers
LIST OF FIGURES
Figure 1. OTC Transdermal Analgesic Patches Picture
Figure 2. Global OTC Transdermal Analgesic Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Type in 2022
Figure 4. Lidocaine Patches Examples
Figure 5. Diclofenac Patches Examples
Figure 6. Indomethacin Patches Examples
Figure 7. Counter-Irritant Patches Examples
Figure 8. Others Examples
Figure 9. Global OTC Transdermal Analgesic Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Application in 2022
Figure 11. Pharmacy Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global OTC Transdermal Analgesic Patches Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global OTC Transdermal Analgesic Patches Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global OTC Transdermal Analgesic Patches Sales Quantity (2018-2029) & (K Units)
Figure 17. Global OTC Transdermal Analgesic Patches Average Price (2018-2029) & (US$/Unit)
Figure 18. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of OTC Transdermal Analgesic Patches by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 OTC Transdermal Analgesic Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 OTC Transdermal Analgesic Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Region (2018-2029)
Figure 25. North America OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 28. South America OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 30. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Type (2018-2029)
Figure 32. Global OTC Transdermal Analgesic Patches Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Application (2018-2029)
Figure 35. Global OTC Transdermal Analgesic Patches Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America OTC Transdermal Analgesic Patches Consumption Value Market Share by Country (2018-2029)
Figure 40. United States OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe OTC Transdermal Analgesic Patches Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value Market Share by Region (2018-2029)
Figure 56. China OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America OTC Transdermal Analgesic Patches Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. OTC Transdermal Analgesic Patches Market Drivers
Figure 77. OTC Transdermal Analgesic Patches Market Restraints
Figure 78. OTC Transdermal Analgesic Patches Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of OTC Transdermal Analgesic Patches in 2022
Figure 81. Manufacturing Process Analysis of OTC Transdermal Analgesic Patches
Figure 82. OTC Transdermal Analgesic Patches Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. OTC Transdermal Analgesic Patches Picture
Figure 2. Global OTC Transdermal Analgesic Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Type in 2022
Figure 4. Lidocaine Patches Examples
Figure 5. Diclofenac Patches Examples
Figure 6. Indomethacin Patches Examples
Figure 7. Counter-Irritant Patches Examples
Figure 8. Others Examples
Figure 9. Global OTC Transdermal Analgesic Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 10. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Application in 2022
Figure 11. Pharmacy Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global OTC Transdermal Analgesic Patches Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global OTC Transdermal Analgesic Patches Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global OTC Transdermal Analgesic Patches Sales Quantity (2018-2029) & (K Units)
Figure 17. Global OTC Transdermal Analgesic Patches Average Price (2018-2029) & (US$/Unit)
Figure 18. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of OTC Transdermal Analgesic Patches by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 OTC Transdermal Analgesic Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 OTC Transdermal Analgesic Patches Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Region (2018-2029)
Figure 25. North America OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 28. South America OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value (2018-2029) & (USD Million)
Figure 30. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Type (2018-2029)
Figure 32. Global OTC Transdermal Analgesic Patches Average Price by Type (2018-2029) & (US$/Unit)
Figure 33. Global OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global OTC Transdermal Analgesic Patches Consumption Value Market Share by Application (2018-2029)
Figure 35. Global OTC Transdermal Analgesic Patches Average Price by Application (2018-2029) & (US$/Unit)
Figure 36. North America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America OTC Transdermal Analgesic Patches Consumption Value Market Share by Country (2018-2029)
Figure 40. United States OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe OTC Transdermal Analgesic Patches Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe OTC Transdermal Analgesic Patches Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific OTC Transdermal Analgesic Patches Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific OTC Transdermal Analgesic Patches Consumption Value Market Share by Region (2018-2029)
Figure 56. China OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America OTC Transdermal Analgesic Patches Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America OTC Transdermal Analgesic Patches Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa OTC Transdermal Analgesic Patches Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa OTC Transdermal Analgesic Patches Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa OTC Transdermal Analgesic Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. OTC Transdermal Analgesic Patches Market Drivers
Figure 77. OTC Transdermal Analgesic Patches Market Restraints
Figure 78. OTC Transdermal Analgesic Patches Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of OTC Transdermal Analgesic Patches in 2022
Figure 81. Manufacturing Process Analysis of OTC Transdermal Analgesic Patches
Figure 82. OTC Transdermal Analgesic Patches Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
